{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003741","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2025-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.097025+00:00","generated_at":"2026-05-23T16:11:50.216756+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PAVmed subsidiary Lucid Diagnostics closes 14.4M share offering raising ~$16.1M net","bullets":["Lucid Diagnostics closed sale of 14,375,000 shares at $1.20 each, including full exercise of underwriters' option.","Net proceeds expected to be approximately $16.1 million after underwriting discounts and expenses.","Proceeds will be used for working capital and general corporate purposes.","Offering was made under Lucid's existing shelf registration statement (Form S-3) and prospectus supplement dated April 9, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003741","json":"https://secwatch.observer/filing/0001641172-25-003741.json","markdown":"https://secwatch.observer/filing/0001641172-25-003741.md","text":"https://secwatch.observer/filing/0001641172-25-003741.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000164117225003741/0001641172-25-003741-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000164117225003741/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T16:11:50.216756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}